Hjem › Mage-tarmstromale tumorer › California
Kliniske studier for Mage-tarmstromale tumorer i California
11 studier for Mage-tarmstromale tumorer søker deltakere på steder i California.
Byer i California
Offisiell studietekst (engelsk)
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
- GSK Investigational Site, Duarte
- GSK Investigational Site, La Jolla
- GSK Investigational Site, Los Angeles
- og 3 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT07218926A Study to Investigate Velzatinib Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (StrateGIST Frontline)
- GSK Investigational Site, San Francisco
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT07585266A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- City of Hope - Duarte Cancer Center, Duarte
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06760819DESTINY-PANTUMOUR04
- Research Site, San Diego
RekruttererObservasjonsstudie
Alder 18 til 130 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07124000KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line)
- USC Norris Comprehensive Cancer Center, Los Angeles
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 10. aug. 2026 · NCT07406633A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Precision NextGen Oncology & Research Center, Beverly Hills
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
- University of California Los Angeles Rheumatology, Westwood, Los Angeles
RekruttererFase 2
Alder 8 og eldre · Alle kjønn · Oppdatert 27. jul. 2026 · NCT05503797A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies
- University of Southern California - Norris Comprehensive Cancer Center, Los Angeles
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 23. jul. 2026 · NCT05957367Preoperative Imatinib and Fampridine in KIT Mutant Gastrointestinal Stromal Tumor
- University of California, San Diego, La Jolla
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 27. mai 2026 · NCT07171203A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
- University of California, San Diego, La Jolla
- University of Southern California, Los Angeles
- University Of California, Irvine, Orange
- og 2 flere
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 5. feb. 2026 · NCT06655246A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST)
- UC San Diego Moores Cancer Center, La Jolla
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 5. feb. 2026 · NCT06630234Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- Stanford University School of Medicine, Stanford
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 18. des. 2025 · NCT01048281Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.